Get the Stockscreener App
0.8001
1.54%
-0.0125
After Hours:
.79
-0.0101
-1.26%
Longeveron Inc stock is traded at $0.8001, with a volume of 416.84K.
It is down -1.54% in the last 24 hours and up +1.59% over the past month.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.
See More
Previous Close:
$0.8126
Open:
$0.81
24h Volume:
416.84K
Relative Volume:
0.47
Market Cap:
$15.66M
Revenue:
$1.89M
Net Income/Loss:
$-17.92M
P/E Ratio:
-0.1196
EPS:
-6.69
Net Cash Flow:
$-15.62M
1W Performance:
+1.21%
1M Performance:
+1.59%
6M Performance:
-46.30%
1Y Performance:
-55.30%
1-Day Range:
$0.775
$0.845
1-Week Range:
$0.775
$0.99
52-Week Range:
$0.633
$2.4843
Longeveron Inc Stock (LGVN) Company Profile
Name
Longeveron Inc
Sector
Industry
Phone
305-302-7158
Address
1951 NW 7TH AVENUE, MIAMI
Compare LGVN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LGVN
Longeveron Inc
|
0.8001 | 17.11M | 1.89M | -17.92M | -15.62M | -6.69 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Longeveron Inc Stock (LGVN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-06-24 | Initiated | ROTH MKM | Buy |
Longeveron Inc Stock (LGVN) Latest News
Will Longeveron Inc. stock continue dividend increases2025 AllTime Highs & Accurate Trade Setup Notifications - newser.com
Longeveron Inc. stock outlook for YEARTrade Exit Summary & Real-Time Stock Entry Alerts - newser.com
Using RSI to spot recovery in Longeveron Inc.Global Markets & Fast Gain Stock Tips - newser.com
Is Longeveron Inc. stock overvalued by current metricsTrade Exit Report & Technical Entry and Exit Alerts - newser.com
Signal strength of Longeveron Inc. stock in tech scannersMarket Movement Recap & Detailed Earnings Play Alerts - newser.com
Will Longeveron Inc. stock outperform tech sector in 2025GDP Growth & Weekly Market Pulse Alerts - newser.com
Tick level data insight on Longeveron Inc. volatilityWeekly Trend Report & Daily Chart Pattern Signals - newser.com
What high frequency data says about Longeveron Inc.Trade Analysis Summary & Daily Profit Focused Stock Screening - newser.com
Real time breakdown of Longeveron Inc. stock performanceLayoff News & AI Based Buy and Sell Signals - newser.com
After-Hours Surge: Turn Therapeutics Rockets 134% Post-Close On Nasdaq Debut; Biotech Stocks Rally - RTTNews
What drives Longeveron Inc stock priceCovered Call Writing & Outstanding Portfolio Growth - earlytimes.in
Longeveron® to Participate in the 4th Annual ROTH Healthcare Opportunities Conference - The Manila Times
What earnings revisions data tells us about Longeveron Inc.2025 Investor Takeaways & Stock Portfolio Risk Management - newser.com
Forecasting Longeveron Inc. price range with options dataJuly 2025 Selloffs & Free AI Powered Buy and Sell Recommendations - newser.com
Custom strategy builders for tracking Longeveron Inc.July 2025 Earnings & Weekly Top Gainers Trade List - newser.com
Using portfolio simulators with Longeveron Inc. includedBond Market & Safe Capital Growth Tips - newser.com
Published on: 2025-10-05 02:00:03 - newser.com
Will Longeveron Inc. bounce back from current supportJuly 2025 Trade Ideas & Free Real-Time Market Sentiment Alerts - newser.com
Published on: 2025-10-03 03:24:01 - newser.com
Leading vs lagging indicators on Longeveron Inc. performanceMarket Risk Analysis & Trade Opportunity Analysis Reports - newser.com
Longeveron Appoints Dr. George Paletta to Board - The Globe and Mail
Longeveron adds Cardinals team doctor to board of directors By Investing.com - Investing.com Nigeria
Longeveron adds Cardinals team doctor to board of directors - Investing.com India
George Paletta, Jr., MD, MBA, Internationally Acclaimed Entrepreneur, Investor and Surgeon, Elected to Longeveron® Board of Directors - The Manila Times
George Paletta, Jr., MD, MBA, Internationally Acclaimed - GlobeNewswire
$1B Healthcare Deal Maker and St. Louis Cardinals Team Doctor Joins Longeveron's Board for Stem Cell Push - Stock Titan
Longeveron (NASDAQ:LGVN) Stock Price Down 2.6% – Here’s Why - Defense World
Longeveron Inc Stock (LGVN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Longeveron Inc Stock (LGVN) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Soffer Rock | Director |
May 29 '25 |
Sale |
1.30 |
10,000 |
13,000 |
220,034 |
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):